Astrazeneca Ab Drug Patent Portfolio

Astrazeneca Ab's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Astrazeneca Ab News

Pharmaceutical companies seek AI partnerships to offset revenue declines from expiring patents.

09 Feb, 2026

JNJ vs. AZN: Which Pharmaceutical Stock is the Better Investment? - TradingView

06 Jan, 2026

ABBV or AZN: Which Pharmaceutical Stock Represents a Superior Investment Opportunity at This Time? - TradingView

23 Dec, 2025

5 Major Pharmaceutical Stocks Likely to Excel in 2026 - TradingView

23 Dec, 2025

See More